Periodontitis clinical trials at UCSF

1 research study open to eligible people

Periodontitis is a serious gum infection that damages soft tissue and bone. UCSF is studying if the drug Valacyclovir can help treat this condition. They are currently recruiting participants for this clinical trial.

Showing trials for

  • Systemic Valacyclovir (Valtrex) on Periodontitis

    open to eligible people ages 18-80

    The experiment outlined in this proposal is designed to test the hypothesis that herpesvirus suppression by the systemic anti-herpesvirus valacyclovir (Valtrex) can significantly help to arrest the progressive course of severe marginal periodontitis in adult patients. A prospective, randomized, placebo-controlled, double-blind, clinical trial is employed to test this hypothesis.

    San Francisco, California

Our lead scientists for Periodontitis research studies include .

Last updated: